This trial will investigate whether the drug gabapentin can help improve sleep for people in the ICU.
1 Primary · 5 Secondary · Reporting Duration: for 12 hours after gabapentin administration
Experimental Treatment
80 Total Participants · 1 Treatment Group
Primary Treatment: Gabapentin 300 mg PO at 8 PM · No Placebo Group · Phase < 1
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: